nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC1—Vemurafenib—melanoma	0.0855	0.136	CbGbCtD
Verapamil—ABCC10—Docetaxel—melanoma	0.076	0.121	CbGbCtD
Verapamil—ABCB1—melanoma	0.0642	1	CbGaD
Verapamil—ABCG2—Vemurafenib—melanoma	0.0572	0.091	CbGbCtD
Verapamil—ABCC1—Dactinomycin—melanoma	0.0568	0.0903	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—melanoma	0.054	0.0859	CbGbCtD
Verapamil—ABCG2—Dactinomycin—melanoma	0.038	0.0605	CbGbCtD
Verapamil—CYP1A2—Carmustine—melanoma	0.0298	0.0475	CbGbCtD
Verapamil—ABCC1—Docetaxel—melanoma	0.0293	0.0466	CbGbCtD
Verapamil—CYP1A2—Vemurafenib—melanoma	0.0236	0.0375	CbGbCtD
Verapamil—CYP3A4—Temozolomide—melanoma	0.0226	0.0359	CbGbCtD
Verapamil—ABCC2—Docetaxel—melanoma	0.0217	0.0345	CbGbCtD
Verapamil—ABCG2—Docetaxel—melanoma	0.0196	0.0312	CbGbCtD
Verapamil—CYP2D6—Vemurafenib—melanoma	0.0194	0.0309	CbGbCtD
Verapamil—CYP1A2—Dacarbazine—melanoma	0.0181	0.0288	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0145	0.0231	CbGbCtD
Verapamil—CYP3A7—Docetaxel—melanoma	0.0145	0.0231	CbGbCtD
Verapamil—ABCB1—Dactinomycin—melanoma	0.0137	0.0218	CbGbCtD
Verapamil—CACNA1S—pes—melanoma	0.0127	0.279	CbGeAlD
Verapamil—CYP3A4—Vemurafenib—melanoma	0.0124	0.0197	CbGbCtD
Verapamil—CYP3A5—Docetaxel—melanoma	0.0109	0.0173	CbGbCtD
Verapamil—ABCB1—Docetaxel—melanoma	0.00708	0.0113	CbGbCtD
Verapamil—Hyperkeratosis—Vemurafenib—melanoma	0.00527	0.0558	CcSEcCtD
Verapamil—CYP3A4—Docetaxel—melanoma	0.00424	0.00674	CbGbCtD
Verapamil—Hyperkeratosis—Bleomycin—melanoma	0.0032	0.0338	CcSEcCtD
Verapamil—CACNA1D—ear—melanoma	0.00293	0.0645	CbGeAlD
Verapamil—CACNA1F—eye—melanoma	0.00261	0.0574	CbGeAlD
Verapamil—CACNA1F—retina—melanoma	0.00259	0.0569	CbGeAlD
Verapamil—Paralysis—Vemurafenib—melanoma	0.00217	0.023	CcSEcCtD
Verapamil—Hepatotoxicity—Vemurafenib—melanoma	0.00195	0.0207	CcSEcCtD
Verapamil—Vasculitis—Vemurafenib—melanoma	0.00154	0.0163	CcSEcCtD
Verapamil—CACNA1F—head—melanoma	0.00148	0.0326	CbGeAlD
Verapamil—Rash maculo-papular—Vemurafenib—melanoma	0.00137	0.0145	CcSEcCtD
Verapamil—Hepatotoxicity—Dactinomycin—melanoma	0.0011	0.0117	CcSEcCtD
Verapamil—CACNB3—mammalian vulva—melanoma	0.00104	0.0229	CbGeAlD
Verapamil—Hepatotoxicity—Carmustine—melanoma	0.00103	0.0109	CcSEcCtD
Verapamil—Extrapyramidal disorder—Temozolomide—melanoma	0.00102	0.0108	CcSEcCtD
Verapamil—Cholestasis—Temozolomide—melanoma	0.00101	0.0107	CcSEcCtD
Verapamil—Hepatotoxicity—Temozolomide—melanoma	0.000997	0.0106	CcSEcCtD
Verapamil—CACNB4—head—melanoma	0.000974	0.0214	CbGeAlD
Verapamil—Petechiae—Temozolomide—melanoma	0.000936	0.00991	CcSEcCtD
Verapamil—CACNA1A—head—melanoma	0.00093	0.0205	CbGeAlD
Verapamil—ABCC1—hair follicle—melanoma	0.000914	0.0201	CbGeAlD
Verapamil—CACNA1B—head—melanoma	0.000908	0.02	CbGeAlD
Verapamil—Accidental injury—Carmustine—melanoma	0.000901	0.00953	CcSEcCtD
Verapamil—CACNB2—retina—melanoma	0.000875	0.0193	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000836	0.00885	CcSEcCtD
Verapamil—CYP2C18—mammalian vulva—melanoma	0.000831	0.0183	CbGeAlD
Verapamil—CACNA1I—lymph node—melanoma	0.000829	0.0182	CbGeAlD
Verapamil—SLC22A4—neck—melanoma	0.000815	0.0179	CbGeAlD
Verapamil—Hepatic enzyme increased—Temozolomide—melanoma	0.000814	0.00862	CcSEcCtD
Verapamil—CACNA1G—head—melanoma	0.000811	0.0178	CbGeAlD
Verapamil—Respiratory failure—Temozolomide—melanoma	0.000784	0.0083	CcSEcCtD
Verapamil—CACNB1—head—melanoma	0.000778	0.0171	CbGeAlD
Verapamil—CACNB3—head—melanoma	0.000746	0.0164	CbGeAlD
Verapamil—Oedema peripheral—Vemurafenib—melanoma	0.000746	0.00789	CcSEcCtD
Verapamil—Ileus—Docetaxel—melanoma	0.000724	0.00766	CcSEcCtD
Verapamil—Injury—Bleomycin—melanoma	0.000721	0.00763	CcSEcCtD
Verapamil—Erythema multiforme—Vemurafenib—melanoma	0.000716	0.00757	CcSEcCtD
Verapamil—Gynaecomastia—Carmustine—melanoma	0.000713	0.00755	CcSEcCtD
Verapamil—Cerebrovascular accident—Bleomycin—melanoma	0.000676	0.00716	CcSEcCtD
Verapamil—Alopecia—Vemurafenib—melanoma	0.000669	0.00708	CcSEcCtD
Verapamil—Hepatotoxicity—Docetaxel—melanoma	0.000663	0.00702	CcSEcCtD
Verapamil—CACNA1B—lymph node—melanoma	0.000636	0.014	CbGeAlD
Verapamil—Lethargy—Dactinomycin—melanoma	0.000631	0.00668	CcSEcCtD
Verapamil—Injury—Carmustine—melanoma	0.000629	0.00666	CcSEcCtD
Verapamil—Vascular purpura—Temozolomide—melanoma	0.000625	0.00662	CcSEcCtD
Verapamil—Purpura—Temozolomide—melanoma	0.00058	0.00614	CcSEcCtD
Verapamil—Diplopia—Carmustine—melanoma	0.000579	0.00612	CcSEcCtD
Verapamil—Bronchospasm—Bleomycin—melanoma	0.000563	0.00596	CcSEcCtD
Verapamil—Arthralgia—Vemurafenib—melanoma	0.000561	0.00594	CcSEcCtD
Verapamil—Myalgia—Vemurafenib—melanoma	0.000561	0.00594	CcSEcCtD
Verapamil—Diplopia—Temozolomide—melanoma	0.000559	0.00592	CcSEcCtD
Verapamil—CACNB1—lymph node—melanoma	0.000545	0.012	CbGeAlD
Verapamil—Anaphylactic shock—Vemurafenib—melanoma	0.000538	0.00569	CcSEcCtD
Verapamil—Infection—Vemurafenib—melanoma	0.000534	0.00565	CcSEcCtD
Verapamil—CACNB3—lymph node—melanoma	0.000522	0.0115	CbGeAlD
Verapamil—Respiratory failure—Docetaxel—melanoma	0.000522	0.00552	CcSEcCtD
Verapamil—ABCC10—mammalian vulva—melanoma	0.000512	0.0113	CbGeAlD
Verapamil—Muscular weakness—Carmustine—melanoma	0.00051	0.0054	CcSEcCtD
Verapamil—Acute coronary syndrome—Bleomycin—melanoma	0.000504	0.00533	CcSEcCtD
Verapamil—Hypotension—Vemurafenib—melanoma	0.000502	0.00532	CcSEcCtD
Verapamil—CACNB2—head—melanoma	0.000501	0.011	CbGeAlD
Verapamil—Myocardial infarction—Bleomycin—melanoma	0.000501	0.0053	CcSEcCtD
Verapamil—Muscular weakness—Temozolomide—melanoma	0.000493	0.00522	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00049	0.00519	CcSEcCtD
Verapamil—KCNJ11—head—melanoma	0.000476	0.0105	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000472	0.005	CcSEcCtD
Verapamil—Sweating increased—Temozolomide—melanoma	0.000471	0.00498	CcSEcCtD
Verapamil—Fatigue—Vemurafenib—melanoma	0.000464	0.00491	CcSEcCtD
Verapamil—Constipation—Vemurafenib—melanoma	0.00046	0.00487	CcSEcCtD
Verapamil—Hypoaesthesia—Bleomycin—melanoma	0.000456	0.00483	CcSEcCtD
Verapamil—Pulmonary oedema—Docetaxel—melanoma	0.000456	0.00483	CcSEcCtD
Verapamil—Upper respiratory tract infection—Temozolomide—melanoma	0.000449	0.00475	CcSEcCtD
Verapamil—Pollakiuria—Temozolomide—melanoma	0.000446	0.00472	CcSEcCtD
Verapamil—Erectile dysfunction—Temozolomide—melanoma	0.000445	0.00471	CcSEcCtD
Verapamil—CACNA1D—head—melanoma	0.000438	0.00964	CbGeAlD
Verapamil—Hepatitis—Dactinomycin—melanoma	0.000428	0.00453	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000427	0.00452	CcSEcCtD
Verapamil—Flushing—Bleomycin—melanoma	0.000426	0.0045	CcSEcCtD
Verapamil—Pharyngitis—Dactinomycin—melanoma	0.000424	0.00449	CcSEcCtD
Verapamil—Alopecia—Bleomycin—melanoma	0.000405	0.00429	CcSEcCtD
Verapamil—CACNA1C—head—melanoma	0.000404	0.0089	CbGeAlD
Verapamil—Erythema multiforme—Dactinomycin—melanoma	0.000404	0.00428	CcSEcCtD
Verapamil—Sinusitis—Temozolomide—melanoma	0.000404	0.00428	CcSEcCtD
Verapamil—Hypoaesthesia—Carmustine—melanoma	0.000398	0.00422	CcSEcCtD
Verapamil—SLC22A5—retina—melanoma	0.000398	0.00875	CbGeAlD
Verapamil—Flushing—Dactinomycin—melanoma	0.000397	0.0042	CcSEcCtD
Verapamil—Hypersensitivity—Vemurafenib—melanoma	0.000396	0.00419	CcSEcCtD
Verapamil—Oedema peripheral—Carmustine—melanoma	0.000394	0.00417	CcSEcCtD
Verapamil—SCN5A—head—melanoma	0.000392	0.00862	CbGeAlD
Verapamil—Hepatitis—Temozolomide—melanoma	0.000387	0.00409	CcSEcCtD
Verapamil—Asthenia—Vemurafenib—melanoma	0.000386	0.00408	CcSEcCtD
Verapamil—Visual impairment—Carmustine—melanoma	0.000386	0.00408	CcSEcCtD
Verapamil—Hypoaesthesia—Temozolomide—melanoma	0.000385	0.00407	CcSEcCtD
Verapamil—Pharyngitis—Temozolomide—melanoma	0.000384	0.00406	CcSEcCtD
Verapamil—Oedema peripheral—Temozolomide—melanoma	0.000381	0.00403	CcSEcCtD
Verapamil—Cardiac failure—Docetaxel—melanoma	0.000381	0.00403	CcSEcCtD
Verapamil—Pruritus—Vemurafenib—melanoma	0.00038	0.00403	CcSEcCtD
Verapamil—Lethargy—Docetaxel—melanoma	0.000379	0.00402	CcSEcCtD
Verapamil—Alopecia—Dactinomycin—melanoma	0.000378	0.004	CcSEcCtD
Verapamil—Visual impairment—Temozolomide—melanoma	0.000373	0.00395	CcSEcCtD
Verapamil—CACNA1H—lymph node—melanoma	0.000372	0.00818	CbGeAlD
Verapamil—Flushing—Carmustine—melanoma	0.000371	0.00393	CcSEcCtD
Verapamil—ABCC3—head—melanoma	0.000368	0.00809	CbGeAlD
Verapamil—Diarrhoea—Vemurafenib—melanoma	0.000368	0.00389	CcSEcCtD
Verapamil—Erythema multiforme—Temozolomide—melanoma	0.000366	0.00387	CcSEcCtD
Verapamil—ABCC1—mammalian vulva—melanoma	0.000362	0.00796	CbGeAlD
Verapamil—Tinnitus—Temozolomide—melanoma	0.000361	0.00382	CcSEcCtD
Verapamil—Flushing—Temozolomide—melanoma	0.000359	0.0038	CcSEcCtD
Verapamil—Dizziness—Vemurafenib—melanoma	0.000356	0.00376	CcSEcCtD
Verapamil—Alopecia—Carmustine—melanoma	0.000354	0.00374	CcSEcCtD
Verapamil—CACNB2—lymph node—melanoma	0.000351	0.00772	CbGeAlD
Verapamil—ABCB1—blood vessel—melanoma	0.00035	0.0077	CbGeAlD
Verapamil—SLC22A5—skin of body—melanoma	0.000349	0.00768	CbGeAlD
Verapamil—Vomiting—Vemurafenib—melanoma	0.000342	0.00362	CcSEcCtD
Verapamil—Alopecia—Temozolomide—melanoma	0.000342	0.00362	CcSEcCtD
Verapamil—Myalgia—Bleomycin—melanoma	0.00034	0.0036	CcSEcCtD
Verapamil—Chest pain—Bleomycin—melanoma	0.00034	0.0036	CcSEcCtD
Verapamil—Orthostatic hypotension—Docetaxel—melanoma	0.00034	0.00359	CcSEcCtD
Verapamil—Rash—Vemurafenib—melanoma	0.000339	0.00359	CcSEcCtD
Verapamil—Dermatitis—Vemurafenib—melanoma	0.000339	0.00359	CcSEcCtD
Verapamil—Headache—Vemurafenib—melanoma	0.000337	0.00357	CcSEcCtD
Verapamil—Discomfort—Bleomycin—melanoma	0.000336	0.00355	CcSEcCtD
Verapamil—Cramp muscle—Docetaxel—melanoma	0.000335	0.00354	CcSEcCtD
Verapamil—KCNJ11—lymph node—melanoma	0.000333	0.00733	CbGeAlD
Verapamil—Confusional state—Bleomycin—melanoma	0.000328	0.00348	CcSEcCtD
Verapamil—Vision blurred—Carmustine—melanoma	0.000328	0.00348	CcSEcCtD
Verapamil—SLC22A1—head—melanoma	0.000328	0.00721	CbGeAlD
Verapamil—Tremor—Carmustine—melanoma	0.000326	0.00346	CcSEcCtD
Verapamil—Anaphylactic shock—Bleomycin—melanoma	0.000326	0.00345	CcSEcCtD
Verapamil—Oedema—Bleomycin—melanoma	0.000326	0.00345	CcSEcCtD
Verapamil—Infection—Bleomycin—melanoma	0.000324	0.00343	CcSEcCtD
Verapamil—Agitation—Carmustine—melanoma	0.00032	0.00339	CcSEcCtD
Verapamil—Nausea—Vemurafenib—melanoma	0.000319	0.00338	CcSEcCtD
Verapamil—Vision blurred—Temozolomide—melanoma	0.000317	0.00336	CcSEcCtD
Verapamil—Myalgia—Dactinomycin—melanoma	0.000317	0.00335	CcSEcCtD
Verapamil—Bronchospasm—Docetaxel—melanoma	0.000316	0.00335	CcSEcCtD
Verapamil—SLCO1A2—head—melanoma	0.000316	0.00694	CbGeAlD
Verapamil—Tremor—Temozolomide—melanoma	0.000315	0.00334	CcSEcCtD
Verapamil—Discomfort—Dactinomycin—melanoma	0.000313	0.00331	CcSEcCtD
Verapamil—Angina pectoris—Docetaxel—melanoma	0.000313	0.00331	CcSEcCtD
Verapamil—Agitation—Temozolomide—melanoma	0.000309	0.00328	CcSEcCtD
Verapamil—Angioedema—Temozolomide—melanoma	0.000308	0.00326	CcSEcCtD
Verapamil—CACNA1D—lymph node—melanoma	0.000307	0.00675	CbGeAlD
Verapamil—SLC6A4—head—melanoma	0.000305	0.00671	CbGeAlD
Verapamil—Hypotension—Bleomycin—melanoma	0.000304	0.00322	CcSEcCtD
Verapamil—Oedema—Dactinomycin—melanoma	0.000304	0.00322	CcSEcCtD
Verapamil—ABCC4—head—melanoma	0.000304	0.00668	CbGeAlD
Verapamil—CYP2B6—skin of body—melanoma	0.000303	0.00667	CbGeAlD
Verapamil—Vertigo—Temozolomide—melanoma	0.000303	0.0032	CcSEcCtD
Verapamil—Convulsion—Carmustine—melanoma	0.000302	0.0032	CcSEcCtD
Verapamil—Infection—Dactinomycin—melanoma	0.000302	0.00319	CcSEcCtD
Verapamil—Hypertension—Carmustine—melanoma	0.000301	0.00318	CcSEcCtD
Verapamil—ABCG2—mammalian vulva—melanoma	0.0003	0.00659	CbGeAlD
Verapamil—Palpitations—Temozolomide—melanoma	0.000298	0.00315	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000297	0.00314	CcSEcCtD
Verapamil—Chest pain—Carmustine—melanoma	0.000297	0.00314	CcSEcCtD
Verapamil—Myalgia—Carmustine—melanoma	0.000297	0.00314	CcSEcCtD
Verapamil—Paraesthesia—Bleomycin—melanoma	0.000293	0.0031	CcSEcCtD
Verapamil—Convulsion—Temozolomide—melanoma	0.000292	0.00309	CcSEcCtD
Verapamil—Hypertension—Temozolomide—melanoma	0.000291	0.00308	CcSEcCtD
Verapamil—Dyspnoea—Bleomycin—melanoma	0.00029	0.00307	CcSEcCtD
Verapamil—Confusional state—Carmustine—melanoma	0.000287	0.00303	CcSEcCtD
Verapamil—Myalgia—Temozolomide—melanoma	0.000287	0.00303	CcSEcCtD
Verapamil—Arthralgia—Temozolomide—melanoma	0.000287	0.00303	CcSEcCtD
Verapamil—Oedema—Carmustine—melanoma	0.000284	0.00301	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000284	0.00301	CcSEcCtD
Verapamil—Discomfort—Temozolomide—melanoma	0.000283	0.003	CcSEcCtD
Verapamil—CACNA1C—lymph node—melanoma	0.000283	0.00623	CbGeAlD
Verapamil—Infection—Carmustine—melanoma	0.000283	0.00299	CcSEcCtD
Verapamil—Acute coronary syndrome—Docetaxel—melanoma	0.000282	0.00299	CcSEcCtD
Verapamil—Myocardial infarction—Docetaxel—melanoma	0.000281	0.00297	CcSEcCtD
Verapamil—Dry mouth—Temozolomide—melanoma	0.00028	0.00297	CcSEcCtD
Verapamil—Jaundice—Docetaxel—melanoma	0.000279	0.00296	CcSEcCtD
Verapamil—Pain—Bleomycin—melanoma	0.000279	0.00295	CcSEcCtD
Verapamil—Tachycardia—Carmustine—melanoma	0.000278	0.00294	CcSEcCtD
Verapamil—Confusional state—Temozolomide—melanoma	0.000277	0.00293	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000277	0.00293	CcSEcCtD
Verapamil—Anaphylactic shock—Temozolomide—melanoma	0.000275	0.00291	CcSEcCtD
Verapamil—Oedema—Temozolomide—melanoma	0.000275	0.00291	CcSEcCtD
Verapamil—Infection—Temozolomide—melanoma	0.000273	0.00289	CcSEcCtD
Verapamil—Feeling abnormal—Bleomycin—melanoma	0.000268	0.00284	CcSEcCtD
Verapamil—Hypotension—Carmustine—melanoma	0.000266	0.00281	CcSEcCtD
Verapamil—Hyperhidrosis—Temozolomide—melanoma	0.000266	0.00281	CcSEcCtD
Verapamil—Fatigue—Dactinomycin—melanoma	0.000262	0.00277	CcSEcCtD
Verapamil—Pain—Dactinomycin—melanoma	0.00026	0.00275	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Carmustine—melanoma	0.000259	0.00274	CcSEcCtD
Verapamil—Urticaria—Bleomycin—melanoma	0.000259	0.00274	CcSEcCtD
Verapamil—Rhinitis—Docetaxel—melanoma	0.000258	0.00273	CcSEcCtD
Verapamil—ABCC3—lymph node—melanoma	0.000258	0.00567	CbGeAlD
Verapamil—Hepatitis—Docetaxel—melanoma	0.000257	0.00272	CcSEcCtD
Verapamil—Insomnia—Carmustine—melanoma	0.000257	0.00272	CcSEcCtD
Verapamil—ABCC10—lymph node—melanoma	0.000256	0.00564	CbGeAlD
Verapamil—Hypoaesthesia—Docetaxel—melanoma	0.000256	0.00271	CcSEcCtD
Verapamil—Paraesthesia—Carmustine—melanoma	0.000255	0.0027	CcSEcCtD
Verapamil—Pharyngitis—Docetaxel—melanoma	0.000255	0.0027	CcSEcCtD
Verapamil—Dyspnoea—Carmustine—melanoma	0.000254	0.00268	CcSEcCtD
Verapamil—Oedema peripheral—Docetaxel—melanoma	0.000253	0.00268	CcSEcCtD
Verapamil—Somnolence—Carmustine—melanoma	0.000253	0.00268	CcSEcCtD
Verapamil—Feeling abnormal—Dactinomycin—melanoma	0.00025	0.00265	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Temozolomide—melanoma	0.00025	0.00265	CcSEcCtD
Verapamil—Insomnia—Temozolomide—melanoma	0.000249	0.00263	CcSEcCtD
Verapamil—Visual impairment—Docetaxel—melanoma	0.000248	0.00262	CcSEcCtD
Verapamil—Paraesthesia—Temozolomide—melanoma	0.000247	0.00261	CcSEcCtD
Verapamil—Dyspnoea—Temozolomide—melanoma	0.000245	0.00259	CcSEcCtD
Verapamil—Somnolence—Temozolomide—melanoma	0.000244	0.00259	CcSEcCtD
Verapamil—Erythema multiforme—Docetaxel—melanoma	0.000243	0.00257	CcSEcCtD
Verapamil—Constipation—Carmustine—melanoma	0.000243	0.00257	CcSEcCtD
Verapamil—Pain—Carmustine—melanoma	0.000243	0.00257	CcSEcCtD
Verapamil—Dyspepsia—Temozolomide—melanoma	0.000242	0.00256	CcSEcCtD
Verapamil—SLC22A4—lymph node—melanoma	0.000241	0.0053	CbGeAlD
Verapamil—KCNH2—head—melanoma	0.000241	0.0053	CbGeAlD
Verapamil—Hypersensitivity—Bleomycin—melanoma	0.00024	0.00254	CcSEcCtD
Verapamil—Flushing—Docetaxel—melanoma	0.000239	0.00253	CcSEcCtD
Verapamil—Fatigue—Temozolomide—melanoma	0.000237	0.00251	CcSEcCtD
Verapamil—Pain—Temozolomide—melanoma	0.000235	0.00249	CcSEcCtD
Verapamil—Constipation—Temozolomide—melanoma	0.000235	0.00249	CcSEcCtD
Verapamil—Feeling abnormal—Carmustine—melanoma	0.000234	0.00248	CcSEcCtD
Verapamil—Asthenia—Bleomycin—melanoma	0.000234	0.00247	CcSEcCtD
Verapamil—Pruritus—Bleomycin—melanoma	0.00023	0.00244	CcSEcCtD
Verapamil—Alopecia—Docetaxel—melanoma	0.000227	0.00241	CcSEcCtD
Verapamil—Feeling abnormal—Temozolomide—melanoma	0.000226	0.0024	CcSEcCtD
Verapamil—Hypersensitivity—Dactinomycin—melanoma	0.000224	0.00237	CcSEcCtD
Verapamil—Urticaria—Temozolomide—melanoma	0.000218	0.00231	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—melanoma	0.000218	0.00231	CcSEcCtD
Verapamil—Muscle spasms—Docetaxel—melanoma	0.000215	0.00228	CcSEcCtD
Verapamil—ABCC4—lymph node—melanoma	0.000213	0.00468	CbGeAlD
Verapamil—Hypersensitivity—Carmustine—melanoma	0.00021	0.00222	CcSEcCtD
Verapamil—Diarrhoea—Dactinomycin—melanoma	0.000208	0.0022	CcSEcCtD
Verapamil—Vomiting—Bleomycin—melanoma	0.000207	0.00219	CcSEcCtD
Verapamil—ABCC2—lymph node—melanoma	0.000206	0.00453	CbGeAlD
Verapamil—Rash—Bleomycin—melanoma	0.000205	0.00217	CcSEcCtD
Verapamil—Dermatitis—Bleomycin—melanoma	0.000205	0.00217	CcSEcCtD
Verapamil—Asthenia—Carmustine—melanoma	0.000204	0.00216	CcSEcCtD
Verapamil—Hypersensitivity—Temozolomide—melanoma	0.000202	0.00214	CcSEcCtD
Verapamil—Syncope—Docetaxel—melanoma	0.000201	0.00213	CcSEcCtD
Verapamil—Palpitations—Docetaxel—melanoma	0.000198	0.00209	CcSEcCtD
Verapamil—CYP2B6—head—melanoma	0.000198	0.00435	CbGeAlD
Verapamil—Asthenia—Temozolomide—melanoma	0.000197	0.00209	CcSEcCtD
Verapamil—Loss of consciousness—Docetaxel—melanoma	0.000197	0.00208	CcSEcCtD
Verapamil—Diarrhoea—Carmustine—melanoma	0.000195	0.00206	CcSEcCtD
Verapamil—Pruritus—Temozolomide—melanoma	0.000194	0.00206	CcSEcCtD
Verapamil—Convulsion—Docetaxel—melanoma	0.000194	0.00205	CcSEcCtD
Verapamil—Nausea—Bleomycin—melanoma	0.000194	0.00205	CcSEcCtD
Verapamil—Hypertension—Docetaxel—melanoma	0.000193	0.00205	CcSEcCtD
Verapamil—Vomiting—Dactinomycin—melanoma	0.000193	0.00204	CcSEcCtD
Verapamil—Rash—Dactinomycin—melanoma	0.000192	0.00203	CcSEcCtD
Verapamil—Arthralgia—Docetaxel—melanoma	0.000191	0.00202	CcSEcCtD
Verapamil—Myalgia—Docetaxel—melanoma	0.000191	0.00202	CcSEcCtD
Verapamil—Chest pain—Docetaxel—melanoma	0.000191	0.00202	CcSEcCtD
Verapamil—Dizziness—Carmustine—melanoma	0.000188	0.00199	CcSEcCtD
Verapamil—Diarrhoea—Temozolomide—melanoma	0.000188	0.00199	CcSEcCtD
Verapamil—Dry mouth—Docetaxel—melanoma	0.000186	0.00197	CcSEcCtD
Verapamil—ABCB1—retina—melanoma	0.000185	0.00406	CbGeAlD
Verapamil—Confusional state—Docetaxel—melanoma	0.000184	0.00195	CcSEcCtD
Verapamil—Anaphylactic shock—Docetaxel—melanoma	0.000183	0.00193	CcSEcCtD
Verapamil—Oedema—Docetaxel—melanoma	0.000183	0.00193	CcSEcCtD
Verapamil—Dizziness—Temozolomide—melanoma	0.000182	0.00192	CcSEcCtD
Verapamil—Infection—Docetaxel—melanoma	0.000182	0.00192	CcSEcCtD
Verapamil—ABCC1—lymph node—melanoma	0.000181	0.00399	CbGeAlD
Verapamil—Vomiting—Carmustine—melanoma	0.000181	0.00191	CcSEcCtD
Verapamil—Nausea—Dactinomycin—melanoma	0.00018	0.00191	CcSEcCtD
Verapamil—Shock—Docetaxel—melanoma	0.00018	0.0019	CcSEcCtD
Verapamil—Rash—Carmustine—melanoma	0.000179	0.0019	CcSEcCtD
Verapamil—Dermatitis—Carmustine—melanoma	0.000179	0.0019	CcSEcCtD
Verapamil—Tachycardia—Docetaxel—melanoma	0.000178	0.00189	CcSEcCtD
Verapamil—Headache—Carmustine—melanoma	0.000178	0.00189	CcSEcCtD
Verapamil—Vomiting—Temozolomide—melanoma	0.000175	0.00185	CcSEcCtD
Verapamil—Rash—Temozolomide—melanoma	0.000173	0.00183	CcSEcCtD
Verapamil—Dermatitis—Temozolomide—melanoma	0.000173	0.00183	CcSEcCtD
Verapamil—Headache—Temozolomide—melanoma	0.000172	0.00182	CcSEcCtD
Verapamil—Hypotension—Docetaxel—melanoma	0.000171	0.00181	CcSEcCtD
Verapamil—Nausea—Carmustine—melanoma	0.000169	0.00179	CcSEcCtD
Verapamil—KCNH2—lymph node—melanoma	0.000169	0.00371	CbGeAlD
Verapamil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000166	0.00176	CcSEcCtD
Verapamil—Insomnia—Docetaxel—melanoma	0.000165	0.00175	CcSEcCtD
Verapamil—Paraesthesia—Docetaxel—melanoma	0.000164	0.00174	CcSEcCtD
Verapamil—Nausea—Temozolomide—melanoma	0.000163	0.00173	CcSEcCtD
Verapamil—Dyspnoea—Docetaxel—melanoma	0.000163	0.00172	CcSEcCtD
Verapamil—Somnolence—Docetaxel—melanoma	0.000162	0.00172	CcSEcCtD
Verapamil—Dyspepsia—Docetaxel—melanoma	0.000161	0.0017	CcSEcCtD
Verapamil—SLC22A5—lymph node—melanoma	0.000159	0.00351	CbGeAlD
Verapamil—Fatigue—Docetaxel—melanoma	0.000158	0.00167	CcSEcCtD
Verapamil—Pain—Docetaxel—melanoma	0.000156	0.00165	CcSEcCtD
Verapamil—Constipation—Docetaxel—melanoma	0.000156	0.00165	CcSEcCtD
Verapamil—Feeling abnormal—Docetaxel—melanoma	0.000151	0.00159	CcSEcCtD
Verapamil—ABCG2—lymph node—melanoma	0.00015	0.0033	CbGeAlD
Verapamil—ABCB1—mammalian vulva—melanoma	0.000148	0.00325	CbGeAlD
Verapamil—CYP2D6—head—melanoma	0.000147	0.00323	CbGeAlD
Verapamil—Hypersensitivity—Docetaxel—melanoma	0.000135	0.00143	CcSEcCtD
Verapamil—Asthenia—Docetaxel—melanoma	0.000131	0.00139	CcSEcCtD
Verapamil—Pruritus—Docetaxel—melanoma	0.000129	0.00137	CcSEcCtD
Verapamil—Diarrhoea—Docetaxel—melanoma	0.000125	0.00132	CcSEcCtD
Verapamil—Dizziness—Docetaxel—melanoma	0.000121	0.00128	CcSEcCtD
Verapamil—Vomiting—Docetaxel—melanoma	0.000116	0.00123	CcSEcCtD
Verapamil—Rash—Docetaxel—melanoma	0.000115	0.00122	CcSEcCtD
Verapamil—Dermatitis—Docetaxel—melanoma	0.000115	0.00122	CcSEcCtD
Verapamil—Headache—Docetaxel—melanoma	0.000114	0.00121	CcSEcCtD
Verapamil—Nausea—Docetaxel—melanoma	0.000109	0.00115	CcSEcCtD
Verapamil—ABCB1—head—melanoma	0.000106	0.00233	CbGeAlD
Verapamil—ABCB1—lymph node—melanoma	7.4e-05	0.00163	CbGeAlD
Verapamil—CYP3A4—Metabolism—GPAM—melanoma	3.95e-06	2.36e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—melanoma	3.93e-06	2.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—FASN—melanoma	3.91e-06	2.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—VCAN—melanoma	3.9e-06	2.34e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNA11—melanoma	3.9e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP17A1—melanoma	3.89e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ABCB1—melanoma	3.88e-06	2.32e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP17A1—melanoma	3.86e-06	2.31e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SLC5A5—melanoma	3.84e-06	2.3e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	3.82e-06	2.29e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTEN—melanoma	3.82e-06	2.29e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—FASN—melanoma	3.81e-06	2.28e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CG—melanoma	3.81e-06	2.28e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CD—melanoma	3.81e-06	2.28e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.8e-06	2.28e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ABCB1—melanoma	3.79e-06	2.27e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CG—melanoma	3.78e-06	2.26e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTEN—melanoma	3.76e-06	2.25e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—melanoma	3.76e-06	2.25e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	3.75e-06	2.25e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SLC5A5—melanoma	3.75e-06	2.25e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1B—melanoma	3.72e-06	2.23e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNAQ—melanoma	3.71e-06	2.22e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CD44—melanoma	3.71e-06	2.22e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.7e-06	2.21e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CB—melanoma	3.69e-06	2.21e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—melanoma	3.68e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNA11—melanoma	3.67e-06	2.2e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTEN—melanoma	3.66e-06	2.19e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—melanoma	3.66e-06	2.19e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—melanoma	3.65e-06	2.18e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNA11—melanoma	3.64e-06	2.18e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.63e-06	2.18e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNAQ—melanoma	3.62e-06	2.17e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CD44—melanoma	3.62e-06	2.17e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CD—melanoma	3.62e-06	2.17e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.6e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—FASN—melanoma	3.59e-06	2.15e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—melanoma	3.57e-06	2.14e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PRKCA—melanoma	3.57e-06	2.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.57e-06	2.14e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—FASN—melanoma	3.56e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1B1—melanoma	3.56e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ERCC2—melanoma	3.54e-06	2.12e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SLC5A5—melanoma	3.54e-06	2.12e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.52e-06	2.11e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CG—melanoma	3.52e-06	2.11e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—melanoma	3.52e-06	2.11e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SLC5A5—melanoma	3.5e-06	2.1e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PRKCA—melanoma	3.49e-06	2.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1B1—melanoma	3.47e-06	2.08e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—melanoma	3.47e-06	2.08e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ERCC2—melanoma	3.46e-06	2.07e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1A—melanoma	3.43e-06	2.06e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTEN—melanoma	3.43e-06	2.05e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNAQ—melanoma	3.41e-06	2.04e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CD44—melanoma	3.41e-06	2.04e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—melanoma	3.4e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNAQ—melanoma	3.38e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CD44—melanoma	3.38e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLA2G6—melanoma	3.35e-06	2.01e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CD—melanoma	3.35e-06	2.01e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CD—melanoma	3.32e-06	1.99e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CB—melanoma	3.32e-06	1.99e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.31e-06	1.98e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—melanoma	3.31e-06	1.98e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—melanoma	3.31e-06	1.98e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP17A1—melanoma	3.29e-06	1.97e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—melanoma	3.29e-06	1.97e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.28e-06	1.97e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ABCB1—melanoma	3.28e-06	1.97e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—melanoma	3.28e-06	1.97e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—melanoma	3.28e-06	1.96e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1B1—melanoma	3.27e-06	1.96e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.25e-06	1.95e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1B1—melanoma	3.24e-06	1.94e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.21e-06	1.92e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTEN—melanoma	3.19e-06	1.91e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CB—melanoma	3.16e-06	1.89e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.14e-06	1.88e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—melanoma	3.13e-06	1.87e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNA11—melanoma	3.11e-06	1.86e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CD—melanoma	3.09e-06	1.85e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—melanoma	3.06e-06	1.84e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—melanoma	3.06e-06	1.83e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—melanoma	3.05e-06	1.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—FASN—melanoma	3.04e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PRKCA—melanoma	3.02e-06	1.81e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—VCAN—melanoma	3.01e-06	1.8e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ERCC2—melanoma	3e-06	1.79e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC5A5—melanoma	2.99e-06	1.79e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ABCB1—melanoma	2.93e-06	1.76e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK3—melanoma	2.93e-06	1.75e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CB—melanoma	2.92e-06	1.75e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CB—melanoma	2.9e-06	1.73e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—melanoma	2.9e-06	1.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNAQ—melanoma	2.89e-06	1.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CD44—melanoma	2.89e-06	1.73e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—melanoma	2.88e-06	1.73e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—melanoma	2.87e-06	1.72e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTEN—melanoma	2.87e-06	1.72e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.86e-06	1.72e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—melanoma	2.85e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.83e-06	1.7e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—melanoma	2.83e-06	1.7e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.81e-06	1.68e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CG—melanoma	2.8e-06	1.67e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK1—melanoma	2.79e-06	1.67e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—melanoma	2.79e-06	1.67e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1B1—melanoma	2.77e-06	1.66e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CG—melanoma	2.73e-06	1.64e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTEN—melanoma	2.73e-06	1.63e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—melanoma	2.7e-06	1.62e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—melanoma	2.7e-06	1.62e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PRKCA—melanoma	2.7e-06	1.62e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CB—melanoma	2.7e-06	1.61e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ABCB1—melanoma	2.7e-06	1.61e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—melanoma	2.69e-06	1.61e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—melanoma	2.68e-06	1.61e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ERCC2—melanoma	2.67e-06	1.6e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ABCB1—melanoma	2.67e-06	1.6e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—melanoma	2.67e-06	1.6e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—melanoma	2.66e-06	1.59e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—melanoma	2.64e-06	1.58e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PRKCA—melanoma	2.63e-06	1.58e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—melanoma	2.63e-06	1.58e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ERCC2—melanoma	2.61e-06	1.56e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—melanoma	2.58e-06	1.55e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP17A1—melanoma	2.54e-06	1.52e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTEN—melanoma	2.53e-06	1.51e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTEN—melanoma	2.5e-06	1.5e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.48e-06	1.49e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PRKCA—melanoma	2.48e-06	1.49e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ERCC2—melanoma	2.46e-06	1.47e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PRKCA—melanoma	2.46e-06	1.47e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CD—melanoma	2.46e-06	1.47e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.45e-06	1.47e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ERCC2—melanoma	2.44e-06	1.46e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—melanoma	2.43e-06	1.45e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—melanoma	2.42e-06	1.45e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CD—melanoma	2.4e-06	1.44e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNA11—melanoma	2.4e-06	1.44e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—melanoma	2.37e-06	1.42e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CG—melanoma	2.37e-06	1.42e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—melanoma	2.36e-06	1.41e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—FASN—melanoma	2.35e-06	1.41e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTEN—melanoma	2.33e-06	1.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC5A5—melanoma	2.31e-06	1.38e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—melanoma	2.28e-06	1.37e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ABCB1—melanoma	2.28e-06	1.37e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—melanoma	2.25e-06	1.35e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—melanoma	2.24e-06	1.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNAQ—melanoma	2.23e-06	1.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CD44—melanoma	2.23e-06	1.34e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.22e-06	1.33e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—melanoma	2.2e-06	1.32e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—melanoma	2.17e-06	1.3e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CB—melanoma	2.14e-06	1.28e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—melanoma	2.14e-06	1.28e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1B1—melanoma	2.14e-06	1.28e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—melanoma	2.12e-06	1.27e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CG—melanoma	2.11e-06	1.27e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—melanoma	2.11e-06	1.26e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PRKCA—melanoma	2.1e-06	1.26e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CB—melanoma	2.09e-06	1.25e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ERCC2—melanoma	2.08e-06	1.25e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CD—melanoma	2.08e-06	1.25e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—melanoma	2.07e-06	1.24e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CG—melanoma	2.06e-06	1.23e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—melanoma	2.05e-06	1.23e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—melanoma	2.04e-06	1.22e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—melanoma	2.02e-06	1.21e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.02e-06	1.21e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—melanoma	1.99e-06	1.19e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—melanoma	1.97e-06	1.18e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CG—melanoma	1.94e-06	1.16e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CG—melanoma	1.93e-06	1.15e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—melanoma	1.92e-06	1.15e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—melanoma	1.88e-06	1.12e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—melanoma	1.86e-06	1.11e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CD—melanoma	1.86e-06	1.11e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTEN—melanoma	1.85e-06	1.11e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—melanoma	1.84e-06	1.1e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—melanoma	1.83e-06	1.1e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CB—melanoma	1.81e-06	1.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CD—melanoma	1.81e-06	1.09e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTEN—melanoma	1.81e-06	1.08e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—melanoma	1.8e-06	1.08e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—melanoma	1.79e-06	1.07e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—melanoma	1.78e-06	1.07e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—melanoma	1.77e-06	1.06e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCB1—melanoma	1.76e-06	1.06e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.73e-06	1.03e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CD—melanoma	1.71e-06	1.02e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CD—melanoma	1.69e-06	1.01e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—melanoma	1.69e-06	1.01e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—melanoma	1.67e-06	1e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—melanoma	1.65e-06	9.9e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CG—melanoma	1.65e-06	9.86e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—melanoma	1.64e-06	9.84e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PRKCA—melanoma	1.62e-06	9.71e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CB—melanoma	1.62e-06	9.69e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ERCC2—melanoma	1.61e-06	9.63e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—melanoma	1.6e-06	9.61e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—melanoma	1.59e-06	9.51e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CB—melanoma	1.58e-06	9.46e-06	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—melanoma	1.57e-06	9.41e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTEN—melanoma	1.57e-06	9.39e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—melanoma	1.57e-06	9.38e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CB—melanoma	1.49e-06	8.92e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CB—melanoma	1.48e-06	8.84e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—melanoma	1.48e-06	8.83e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—melanoma	1.46e-06	8.76e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—melanoma	1.46e-06	8.72e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CD—melanoma	1.45e-06	8.67e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—melanoma	1.44e-06	8.64e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—melanoma	1.43e-06	8.56e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTEN—melanoma	1.4e-06	8.38e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTEN—melanoma	1.37e-06	8.18e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—melanoma	1.34e-06	8.04e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—melanoma	1.31e-06	7.82e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTEN—melanoma	1.29e-06	7.7e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—melanoma	1.28e-06	7.64e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTEN—melanoma	1.28e-06	7.64e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CG—melanoma	1.27e-06	7.61e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CB—melanoma	1.26e-06	7.55e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—melanoma	1.25e-06	7.48e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—melanoma	1.23e-06	7.34e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CD—melanoma	1.12e-06	6.69e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—melanoma	1.11e-06	6.62e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—melanoma	1.1e-06	6.6e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTEN—melanoma	1.09e-06	6.53e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—melanoma	1.07e-06	6.39e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—melanoma	1.04e-06	6.24e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—melanoma	9.87e-07	5.91e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CB—melanoma	9.73e-07	5.83e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—melanoma	9.64e-07	5.78e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—melanoma	9.63e-07	5.77e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—melanoma	9.08e-07	5.44e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—melanoma	9.03e-07	5.41e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—melanoma	9e-07	5.39e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTEN—melanoma	8.41e-07	5.04e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—melanoma	8.06e-07	4.83e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—melanoma	7.87e-07	4.71e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—melanoma	7.69e-07	4.6e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—melanoma	7.41e-07	4.44e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—melanoma	7.35e-07	4.4e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—melanoma	6.28e-07	3.76e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—melanoma	5.93e-07	3.55e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—melanoma	4.85e-07	2.9e-06	CbGpPWpGaD
